The FDA has approved a five-day dosing regimen for Dacogen (decitabine for injection, from Eisai) to treat patients with myelodysplastic syndromes (MDS).

The FDA has notified healthcare professionals and patients that at this point, the data that have been reviewed have not shown a clear connection between bisphosphonate use and a risk of atypical subtrochanteric femur fractures.

The FDA has approved Trelstar 22.5mg (triptorelin pamoate for injectable suspension, from Watson) for the palliative treatment of advanced prostate cancer.

A search of the literature does not support using beta-blocker therapy in patients at lower risks for cardiac events prior to noncardiac surgery.

Patients who don't respond to their antidepressant should be evaluated carefully for compliance, substance abuse, bipolar disorder, and social stressors. Switching drugs or combination therapy may be warranted.

The American Urological Association and the American Cancer Society disagree over when baseline screening should begin.

Mortality risk for patients who had abnormally high calcium levels for a prolonged period was 31% greater than that of the individuals with normal blood calcium levels

Upper respiratory infection triggers complications in a healthy college student.

A number of diagnostic possibilities are raised, including allergy, asthma, postnasal drip, and reflux.